Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis

Atherosclerosis

Volumn 195, Issue 2, 2007, Pages 374-378

  Saleh, Nawsad ^a   Tornvall, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CRP; PCI; Restenosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; STABLE ANGINA PECTORIS; SURVIVAL RATE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS;

EID: 36048939126     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.10.026     Document Type: Article

References (23)

1. Rajagopal V., and Rockson S. Coronary restenosis: a review of mechanisms and management. Am J Med 115 (2003) 547-553
2. Colombo A., and Iakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascularization. Eur Heart J 25 11 (2004) 895-897
3. Gaspardone A., and Versaci F. Coronary stenting and inflammation. Am J Cardiol 96 Suppl. (2005) 65L-70L
4. Liuzzo G., Buffon A., Biasucci L.M., et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 98 (1998) 2370-2376
5. Azar R.R., McKay R.G., Kiernan F.J., et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 80 (1997) 1476-1478
6. Angioi M., Abdelmouttaleb I., Rodriguez R., et al. Increased C-reactive protein levels in patients with in-stent restenosis and its implications. Am J Cardiol 87 (2001) 1189-1193
7. Gottsauner-Wolf M., Zasmeta G., Hornykewycz S., et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 21 (2000) 1152-1158
8. Buffon A., Liuzzo G., Biasucci L.M., et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 34 (1999) 1512-1521
9. Gaspardone A., Crea F., Versaci F., et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 82 (1998) 515-518
10. Walter D.H., Fichtlscherer S., Sellwig M., et al. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
11. Saleh N., Svane B., Hansson L.O., et al. Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value. Clin Chem 51 11 (2005) 2124-2130
12. Ohkawa F., Ikeda U., Kanbe T., et al. Effects of inflammatory cytokines on vascular tone. Cardiovasc Res 30 (1995) 711-715
13. Smeeth L., Thomas S., Hall A., et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351 25 (2004 Dec 16) 2611-2618
14. Bennermo M., Held C., Ericsson C.G., et al. Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction?. Throm Haemost 94 (2005) 427-431
15. Braunwald E. Unstable angina: a classification. Circulation 80 (1989) 410-414
16. Dibra A., Mehilli J., Braun S., et al. Association between C-reactive protein levels and subsquent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114 (2003) 715-722
17. Zhou Y., Csako G., Grayston T., et al. Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. Am J Cardiol 84 (1999) 595-598
18. Horne B., Muhlestein J., Strobel G., Carlquist J., Bair T., and Andersson J. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 144 (2002) 491-500
19. Hong Y., Jeong M., Lim S., et al. Relation of soft plaque and elevated preprocedural high sensitivity C-reactive protein levels to incidence of in-stent restenosis after successful coronary artery stenting. Am J Cardiol 98 (2006) 341-345
20. Dibra A., Mehilli J., Braun S., et al. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Am Heart J 150 (2005) 344-350
21. Gaspardone A., Versaci F., Tomai F., et al. C-reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents. Am J Cardiol 97 (2006) 1311-1316
22. Weintraub W., Ghazzal Z., Douglas J., et al. Usefulness of the substitusion of nonangiographic end points (death, acute myocardial infarction, coronary bypass and/or repeat angioplasty) for follow-up coronary angiography in evaluating the success of coronary angioplasty in patients with angina pectoris. Am J Cardiol 81 (1998) 382-386
23. Hahn J., Kom H., Koo B., et al. One month follow-up C-reactive protein may be a useful predictor of angiographic restenosis and long-term clinical outcomes after bare metal stent implantation. Int J Cardiol 109 (2006) 267-269